Heron Neutron Medical Stock Forecast

Stock Price Forecast

According to 3 analysts polled by S&P Global, Heron Neutron Medical stock has a consensus rating of "Strong Buy" and an average price target of $1,203. The average 1-year stock price forecast is 191.36% higher than the current stock price, while the lowest is $1,100 (+166.34%) and the highest is $1,260 (+205.08%).

Price Target: $1,203 (+191.36%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$1,100	$1,203	$1,250	$1,260
Change	+166.34%	+191.36%	+202.66%	+205.08%

Analyst Ratings

The average analyst rating for Heron Neutron Medical stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Oct '25	Nov '25	Dec '25	Feb '26	Jun '26
Strong Buy	1	2	3	3	3
Buy	0	0	0	0	0
Hold	0	0	0	0	0
Sell	0	0	0	0	0
Strong Sell	0	0	0	0	0
Total	1	2	3	3	3

Financial Forecast

Revenue This Year

25.00M

from 10.31M

142.53%

from 10.31M

Revenue Next Year

3.44B

from 25.00M

13,668.00%

from 25.00M

EPS This Year

-0.89

from -3.31

EPS Next Year

9.57

from -0.89

Fiscal Year	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	-	238.00K	-	10.31M	25.00M
Revenue Growth	-	-	-	-	142.53%
Operating Income	-87.80M	-129.51M	-259.00M	-534.32M	-489.28M
Net Income	-86.18M	-126.39M	-260.08M	-481.67M	-398.00M
EPS	-	-	-	-3.31	-0.89
No. Analysts	-	-	-	-	1

EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is TWD.

Revenue Forecast

Revenue	2026	2027
High	25.0M
Avg	25.0M
Low	25.0M

Revenue Growth

Revenue Growth	2026	2027
High	142.5%
Avg	142.5%
Low	142.5%

EPS Forecast

EPS	2026	2027
High	-0.89
Avg	-0.89
Low	-0.89

EPS Growth

EPS Growth	2026	2027
High	-
Avg	-
Low	-